Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Voya Financial
VOYA
|
+$81.9M |
| 2 |
SPR
Spirit AeroSystems
SPR
|
+$68.8M |
| 3 |
Goldman Sachs
GS
|
+$64.1M |
| 4 |
AbbVie
ABBV
|
+$58.2M |
| 5 |
Citigroup
C
|
+$38.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$85.8M |
| 2 |
LO
LORILLARD INC COM STK
LO
|
+$60.3M |
| 3 |
Morgan Stanley
MS
|
+$52.6M |
| 4 |
Expedia Group
EXPE
|
+$47.8M |
| 5 |
Centene
CNC
|
+$41.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.2% |
| 2 | Financials | 14.02% |
| 3 | Technology | 13.59% |
| 4 | Industrials | 10.74% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Travere Therapeutics
TVTX
$5.68B
| $3.39M | ﹤0.01% |
102,308
+47,484
| +87% | +$1.3M |
|
|
SAFE
1802
Safehold
SAFE
$1.08B
| $3.39M | ﹤0.01% |
52,218
-17,289
| -25% | -$1.17M |
|
|
AEGN
1803
DELISTED
Aegion Corp
AEGN
| $3.38M | ﹤0.01% |
178,191
+22,848
| +15% | +$420K |
|
1804
LSB Industries
LXU
$719M
| $3.37M | ﹤0.01% |
107,329
+3,963
| +4% | +$130K |
|
1805
EXL Service
EXLS
$5.29B
| $3.35M | ﹤0.01% |
484,425
+14,075
| +3% | +$97.8K |
|
|
EGOV
1806
DELISTED
NIC Inc
EGOV
| $3.35M | ﹤0.01% |
183,246
+5,554
| +3% | +$97K |
|
1807
Coherent
COHR
$64.3B
| $3.33M | ﹤0.01% |
175,433
+34,736
| +25% | +$647K |
|
|
BPFH
1808
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $3.33M | ﹤0.01% |
248,164
+7,870
| +3% | +$101K |
|
1809
Groupon
GRPN
$889M
| $3.33M | ﹤0.01% |
33,054
-2,710
| -8% | -$350K |
|
|
TCF
1810
DELISTED
TCF Financial Corporation Common Stock
TCF
| $3.32M | ﹤0.01% |
100,340
+2,941
| +3% | +$92.8K |
|
|
ARNA
1811
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $3.31M | ﹤0.01% |
71,319
+2,125
| +3% | +$92.2K |
|
|
TUMI
1812
DELISTED
TUMI HLDGS INC COM
TUMI
| $3.31M | ﹤0.01% |
161,233
+5,441
| +3% | +$119K |
|
1813
Kforce
KFRC
$1.04B
| $3.3M | ﹤0.01% |
144,304
+8,106
| +6% | +$180K |
|
1814
McGrath RentCorp
MGRC
$2.95B
| $3.3M | ﹤0.01% |
108,477
+8,899
| +9% | +$286K |
|
|
ALX
1815
Alexander's
ALX
$1.39B
| $3.3M | ﹤0.01% |
8,042
+287
| +4% | +$122K |
|
|
ARRY
1816
DELISTED
Array Biopharma Inc
ARRY
| $3.3M | ﹤0.01% |
457,131
+12,081
| +3% | +$89.2K |
|
|
BEL
1817
DELISTED
Belmond Ltd.
BEL
| $3.29M | ﹤0.01% |
263,693
-3,906
| -1% | -$49.4K |
|
1818
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
| $3.29M | ﹤0.01% |
64,500
-17,700
| -22% | -$923K |
|
1819
Comtech Telecommunications
CMTL
$51.8M
| $3.29M | ﹤0.01% |
113,246
+15,242
| +16% | +$461K |
|
1820
Atlantic Union Bankshares
AUB
$6.02B
| $3.29M | ﹤0.01% |
141,431
+4,109
| +3% | +$91.5K |
|
|
ECOL
1821
DELISTED
US Ecology, Inc.
ECOL
| $3.28M | ﹤0.01% |
67,323
+4,788
| +8% | +$231K |
|
|
INVN
1822
DELISTED
Invensense Inc
INVN
| $3.26M | ﹤0.01% |
215,906
+15,789
| +8% | +$238K |
|
|
EPAY
1823
DELISTED
Bottomline Technologies Inc
EPAY
| $3.25M | ﹤0.01% |
116,841
+3,453
| +3% | +$95.2K |
|
|
FLTX
1824
DELISTED
Fleetmatics Group PLC
FLTX
| $3.24M | ﹤0.01% |
69,268
| – | – |
|
|
RAVN
1825
DELISTED
Raven Industries Inc
RAVN
| $3.24M | ﹤0.01% |
159,344
+18,008
| +13% | +$364K |
|
Similar funds
Charles Schwab's Q2 2015 Portfolio in Review
As of Q2 2015, Charles Schwab held 3,232 positions worth $72.4B, up 1.8% from $71.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab's Q2 2015 filing shows 150 new, 2,258 increased, 427 reduced and 137 closed positions. Its largest new stake was Citizens Financial Group: 394,487 shares worth $10.8M. The largest sale was Merck, an estimated $85.8M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
- Charles Schwab's largest Q2 2015 buy was Citizens Financial Group: 394,487 shares worth $10.8M.
- Charles Schwab added most to Voya Financial in Q2 2015, an estimated $81.9M increase.
- Charles Schwab's biggest Q2 2015 reduction was Merck, cutting an estimated $85.8M.
- Charles Schwab fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $60.3M.
- Charles Schwab's ten largest holdings make up 14% of its $72.4B portfolio in Q2 2015.
- Charles Schwab opened 150 new positions and closed 137 in Q2 2015.
- Charles Schwab's portfolio value rose 1.8% quarter-over-quarter to $72.4B.
Based on Charles Schwab's 13F filing for Q2 2015, filed 14 Aug 2015.